Staphylococcus aureus strains exhibit heterogenous tolerance to direct cold atmospheric plasma therapy

Baz, A. et al. (2023) Staphylococcus aureus strains exhibit heterogenous tolerance to direct cold atmospheric plasma therapy. Biofilm, 5, 100123. (doi: 10.1016/j.bioflm.2023.100123) (PMID:37138646) (PMCID:PMC10149328)

[img] Text
296628.pdf - Published Version
Available under License Creative Commons Attribution.

4MB

Abstract

The global clinical and socioeconomic impact of chronic wounds is substantial. The main difficulty that clinicians face during the treatment of chronic wounds is the risk of infection at the wound site. Infected wounds arise from an accumulation of microbial aggregates in the wound bed, leading to the formation of polymicrobial biofilms that can be largely resistant to antibiotic therapy. Therefore, it is essential for studies to identify novel therapeutics to alleviate biofilm infections. One innovative technique is the use of cold atmospheric plasma (CAP) which has been shown to possess promising antimicrobial and immunomodulatory properties. Here, different clinically relevant biofilm models will be treated with cold atmospheric plasma to assess its efficacy and killing effects. Biofilm viability was assessed using live dead qPCR, and morphological changes associated with CAP evaluated using scanning electron microscopy (SEM). Results indicated that CAP was effective against Candida albicans and Pseudomonas aeruginosa, both as mono-species biofilms and when grown in a triadic model system. CAP also significantly reduced viability in the nosocomial pathogen, Candida auris. Staphylococcus aureus Newman exhibited a level of tolerance to CAP therapy, both when grown alone or in the triadic model when grown alongside C. albicans and P. aeruginosa. However, this degree of tolerance exhibited by S. aureus was strain dependent. At a microscopic level, biofilm treatment led to subtle changes in morphology in the susceptible biofilms, with evidence of cellular deflation and shrinkage. Taken together, these results indicate a promising application of direct CAP therapy in combatting wound and skin-related biofilm infections, although biofilm composition may affect the treatment efficacy.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:BIN AHMED BAKRI, AHMED RAFEZZAN and Brown, Dr Jason and Riggio, Professor Marcello and Butcher, Mr Mark and Ramage, Professor Gordon and Baz, Abdullah and Short, Mr Bryn and Williams, Dr Craig
Authors: Baz, A., Bakri, A., Butcher, M., Short, B., Ghimire, B., Gaur, N., Jenkins, T., Short, R. D., Riggio, M., Williams, C., Ramage, G., and Brown, J. L.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Dental School
Journal Name:Biofilm
Publisher:Elsevier
ISSN:2590-2075
ISSN (Online):2590-2075
Published Online:15 April 2023
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in Biofilm 5: 100123
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
308058Plasma-activated antimicrobial hydrogel therapy (PAHT) for combatting infections in diabetic foot ulcersGordon RamageEngineering and Physical Sciences Research Council (EPSRC)EP/V005839/1Med - Dental School
312246Using Big Data to Model the Maintenance of Health in the Human Oral CavityGordon RamageBiotechnology and Biological Sciences Research Council (BBSRC)BB/V509541/1Med - Dental School